Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Twice-daily Application of Delgocitinib Cream 20 mg/g for 6 Weeks in Subjects With Active Discoid Lupus Erythematosus.

NCT03958955 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT03958955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03958955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Twice-daily Application of Delgocitinib Cream 20 mg/g for 6 Weeks in Subjects With Active Discoid Lupus Erythematosus.
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Terminated
Start date
July 9, 2019
Completion date
April 30, 2020
Enrollment
27 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

discoid lupus erythematosus